- KR₩4tn
- KR₩4tn
- KR₩373bn
- 98
- 16
- 100
- 85
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.49 | ||
| PEG Ratio (f) | 2.06 | ||
| EPS Growth (f) | 12.9% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.95 | ||
| Price to Tang. Book | 6.54 | ||
| Price to Free Cashflow | 34.35 | ||
| Price to Sales | 10.66 | ||
| EV to EBITDA | 22.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.83% | ||
| Return on Equity | 17.51% | ||
| Operating Margin | 39.62% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 211,038.35 | 231,859.11 | 281,675.14 | 319,699.94 | 373,046.89 | 452,756 | 545,899 | 12.77% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.65 | +36.91 | +18.17 | +57.95 | +54.25 | +6.61 | +25.58 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hugel Inc is a Korea-based company mainly engaged in the manufacture of biopharmaceuticals. The Company's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The Company sells its products in domestic and overseas markets.
Directors
- Gyeong Yeop Moon CCE (51)
- Ju Yeop Shim CCE (40)
- Sun Wu Gwon VPR (45)
- Jong Min Kim MDR (45)
- Yik Hwan Cho OTH (46)
- Jae Gyu Hahm OTH (51)
- Dae Geon Kim OTH (47)
- Eun Gap Kim OTH (51)
- Chang Jin Lee OTH (43)
- Si Hwa Yoo NID (48)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 22nd, 2001
- Public Since
- December 24th, 2015
- No. of Shareholders
- 19,562
- No. of Employees
- 126
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 10,999,222
- Address
- 61-20, Sinbuk-ro, Sinbuk-eup, CHUNCHEON, 24206
- Web
- https://www.hugel-inc.com/
- Phone
- +82 338155200
- Auditors
- Samil Accounting Corp.
Upcoming Events for 145020
Q2 2025 Hugel Inc Earnings Release
Similar to 145020
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
What is the Hugel share price?
As of Today at 21:10 UTC, shares in Hugel are trading at KR₩361,500. This share price information is delayed by 15 minutes.
How has the Hugel share price performed this year?
Shares in Hugel last closed at KR₩361,500 and the price had moved by +74.33% over the past 365 days. In terms of relative price strength the Hugel share price has outperformed the FTSE Developed Asia Pacific Index by +76.33% over the past year.
What are the analyst and broker recommendations for Hugel?
The overall consensus recommendation for Hugel is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Hugel dividend yield?
Hugel does not currently pay a dividend.
Does Hugel pay a dividend?
Hugel does not currently pay a dividend.
When does Hugel next pay dividends?
Hugel does not currently pay a dividend.
How do I buy Hugel shares?
To buy shares in Hugel you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hugel?
As of the previous close price of KR₩361,500, shares in Hugel had a market capitalisation of KR₩4tn.
Where are Hugel shares listed?
Here are the trading details for Hugel:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 145020
What kind of share is Hugel?
Based on an overall assessment of its quality, value and momentum Hugel is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hugel share price forecast for 2025?
The analyst consensus target price for shares in Hugel is KR₩420,220. That is 16.24% above the last closing price of KR₩361,500.
Analysts covering Hugel currently have a consensus Earnings Per Share (EPS) forecast of KR₩14,233 for the next financial year.
Find out moreWhat is the trend in the Hugel share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hugel. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +42.07%.
As of the last closing price of KR₩361,500, shares in Hugel were trading +31.12% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hugel PE Ratio?
The Hugel PE ratio based on its reported earnings over the past 12 months is 23.49. The shares last closed at KR₩361,500.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hugel?
Hugel's management team is headed by:
- Gyeong Yeop Moon - CCE
- Ju Yeop Shim - CCE
- Sun Wu Gwon - VPR
- Jong Min Kim - MDR
- Yik Hwan Cho - OTH
- Jae Gyu Hahm - OTH
- Dae Geon Kim - OTH
- Eun Gap Kim - OTH
- Chang Jin Lee - OTH
- Si Hwa Yoo - NID